Leishmaniasis is a worldwide uncontrolled parasitic disease due to the lack of effective drug and vaccine. To speed up effective drug development, we need powerful methods to rapidly assess drug effectiveness against the intracellular form of Leishmania in high throughput assays. Reporter gene technology has proven to be an excellent tool for drug screening in vitro. The effects of reporter proteins on parasite infectivity should be identified both in vitro and in vivo. In this research, we initially compared the infectivity rate of recombinant Leishmania major expressing stably enhanced green fluorescent protein (EGFP) alone or EGFP-luciferase (EGFP-LUC) with the wild-type strain. Next, we evaluated the sensitivity of these parasites to amphotericin B (AmB) as a standard drug in 2 parasitic phases, promastigote and amastigote. This comparison was made by MTT and nitric oxide (NO) assay and by quantifying the specific signals derived from reporter genes like EGFP intensity and luciferase activity. To study the amastigote form, both B10R and THP-1 macrophage cell lines were infected in the stationary phase and were exposed to AmB at different time points. Our results clearly revealed that the 3 parasite lines had similar in vitro infectivity rates with comparable parasite-induced levels of NO following interferon-γ/lipopolysaccharide induction. Based on our results we proposed the more reporter gene, the faster and more sensitive evaluation of the drug efficiency.
Citations
Citations to this article as recorded by
Characterization and Evaluation of Microwave-Synthesized Nanostructured Lipid Carriers for Enhanced Amphotericin B Efficacy Against Leishmania donovani: A Novel Therapeutic Paradigm Sunidhi Lohan, Meenakshi Bhatia BioNanoScience.2024; 14(3): 2782. CrossRef
Insights into the drug screening approaches in leishmaniasis Boobalan Gopu, Parampreet Kour, Ramajayan Pandian, Kuljit Singh International Immunopharmacology.2023; 114: 109591. CrossRef
A short-term method to evaluate anti-leishmania drugs by inhibition of stage differentiation in Leishmania mexicana using flow cytometry Christian Florian Teh-Poot, Victor Manuel Dzul-Huchim, Jonathan M. Mercado, Liliana Estefanía Villanueva-Lizama, Maria Elena Bottazzi, Kathryn M. Jones, Francis T.F. Tsai, Julio Vladimir Cruz-Chan Experimental Parasitology.2023; 249: 108519. CrossRef
Challenges and Tools for In Vitro Leishmania Exploratory Screening in the Drug Development Process: An Updated Review Anita Cohen, Nadine Azas Pathogens.2021; 10(12): 1608. CrossRef
A Survey on Inhibitory Effect of Whole-Body Extraction and Secretions of Lucilia sericata's Larvae on Leishmania major In vitro Maryam Tahmasebi, Simindokht Soleimanifard, Alireza Sanei, Azadeh Karimy, Seyed Mohammad Abtahi Advanced Biomedical Research.2020;[Epub] CrossRef
Potential of the natural products against leishmaniasis in Old World - a review of in-vitro studies Sofia Cortes, Carolina Bruno de Sousa, Thiago Morais, João Lago, Lenea Campino Pathogens and Global Health.2020; 114(4): 170. CrossRef
Sambucus ebulus extract stimulates cellular responses in cutaneous leishmaniasis Maryam Heidari‐Kharaji, Vahid Fallah‐Omrani, Alireza Badirzadeh, Behnam Mohammadi‐Ghalehbin, Mohammad Ali Nilforoushzadeh, Leila Masoori, Hossein Montakhab‐Yeganeh, Mehrak Zare Parasite Immunology.2019;[Epub] CrossRef
In-depth comparison of cell-based methodological approaches to determine drug susceptibility of visceral Leishmania isolates Sarah Hendrickx, Lieselotte Van Bockstal, Guy Caljon, Louis Maes, Kiyoshi Kita PLOS Neglected Tropical Diseases.2019; 13(12): e0007885. CrossRef
Assessment of Leishmania cell lines expressing high levels of beta-galactosidase as alternative tools for the evaluation of anti-leishmanial drug activity Aline C. da Silva Santos, Danielle M.N. Moura, Thiago A.R. dos Santos, Osvaldo P. de Melo Neto, Valéria R.A. Pereira Journal of Microbiological Methods.2019; 166: 105732. CrossRef
Development of NanoLuc-PEST expressing Leishmania mexicana as a new drug discovery tool for axenic- and intramacrophage-based assays Sarah L. Berry, Hamza Hameed, Anna Thomason, Marissa L. Maciej-Hulme, Somaia Saif Abou-Akkada, Paul Horrocks, Helen P. Price, Timothy G. Geary PLOS Neglected Tropical Diseases.2018; 12(7): e0006639. CrossRef
Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites Alireza Badirzadeh, Tahereh Taheri, Yasaman Taslimi, Zahra Abdossamadi, Maryam Heidari-Kharaji, Elham Gholami, Baharehsadat Sedaghat, Maryam Niyyati, Sima Rafati, Armando Jardim PLOS Neglected Tropical Diseases.2017; 11(7): e0005774. CrossRef
Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice Zahra Abdossamadi, Negar Seyed, Farnaz Zahedifard, Tahereh Taheri, Yasaman Taslimi, Hossein Montakhab-Yeganeh, Alireza Badirzadeh, Mohammad Vasei, Safoora Gharibzadeh, Sima Rafati, Michael P. Pollastri PLOS Neglected Tropical Diseases.2017; 11(12): e0006123. CrossRef
A shuttle vector for Escherichia coli and Giardia lamblia was modified to produce a reporter plasmid, which monitors the expression of prescribed gene in G. lamblia by measuring its luciferase activity. Promoter regions of the gap2 gene, one of the genes induced during encystation, were cloned into this plasmid, and the resultant constructs were then transfected into trophozoites of G. lamblia. Transgenic trophozoites containing one of the 3 gap2-luc reporters were induced to encystation, and characterized with respect to gap2 gene expression by measuring their luciferase activities. Giardia containing a gap2-luc fusion of 112-bp upstream region showed full induction of luciferase activity during encystation.
Citations
Citations to this article as recorded by
Eukaryote-conserved histone post-translational modification landscape in Giardia duodenalis revealed by mass spectrometry Samantha J. Emery-Corbin, Joshua J. Hamey, Balu Balan, Laura Rojas-López, Staffan G. Svärd, Aaron R. Jex International Journal for Parasitology.2021; 51(4): 225. CrossRef
First
Prev
